ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DRTS vs AORT // FREE CASH FLOW YIELD

Alpha Tau Medical Ltd. (NASDAQ) VS. Artivion Inc. (NYSE) • 15-METRIC TALLY: DRTS 1 — AORT 4
▲ FREE CASH FLOW YIELD LEADER: AORT
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DRTS VS. AORT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DRTS AORT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 64.40% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 4.50% -39.50 AORT /roic <GO>
EV/EBITDA & P/E Valuation — 19.3x — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -2.68% 0.07% -2.75 AORT /fcf-yield <GO>
Operating Margin — 7.60% — TIE /operating-margins <GO>
Net Profit Margin — 2.20% — TIE /net-margins <GO>
Revenue Growth (YoY) — 13.60% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 2.46 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 9/9 -7.00 AORT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.3 46.6 -3.31 AORT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 98.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.22B $1.14B $80.6M DRTS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DRTS REV AORT REV DRTS GROSS % AORT GROSS % DRTS FCF AORT FCF
FY 2025 $0 $441.3M — 64.4% -$32.8M $839.0K
FY 2024 $0 $388.5M — 64.0% -$22.0M $11.0M
FY 2023 $0 $354.0M — — -$18.0M $18.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DRTS // BETA —
AORT // BETA —